Skip to main content
MedPathMedPath Home
Clinical Trials/NCT01323361
NCT01323361
Completed
Not Applicable

Multi-centre Observational Pilot-study for Evaluation of Variation in CA-125 and Other Inflammatory Markers in the Perioperative Period of Laparoscopic Ventral Hernia Repair

Oslo University Hospital2 sites in 1 country10 target enrollmentApril 2011
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHernia

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hernia
Sponsor
Oslo University Hospital
Enrollment
10
Locations
2
Primary Endpoint
Level of variation in inflammatory markers related to "trauma" impact
Status
Completed
Last Updated
13 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

The study aims to show variation in CA-125 and other inflammatory markers assumed to be a response to trauma and peritoneal inflammation in the perioperative period of laparoscopic ventral hernia repair

Detailed Description

CA-125 and other inflammatory markers as body temperature, CRP, PCT, leucocytes and neutrophils measured pre- and post-operatively - correlated to trauma size i.e. area of dissection, mesh size, number of fixation points etc.

Registry
clinicaltrials.gov
Start Date
April 2011
End Date
August 2012
Last Updated
13 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Oslo University Hospital
Responsible Party
Principal Investigator
Principal Investigator

Jan Lambrecht

MD

Oslo University Hospital

Eligibility Criteria

Inclusion Criteria

  • •Adults admitted for ventral or incisional hernia repair

Exclusion Criteria

  • •Loss-of-domain
  • •ASA above III
  • •Liver failure
  • •Abnormal CA-125 prior to surgery

Outcomes

Primary Outcomes

Level of variation in inflammatory markers related to "trauma" impact

Time Frame: 6 weeks post surgery

Study Sites (2)

Loading locations...

Similar Trials

Not yet recruiting
Not Applicable
Observational Study of Sputum Inflammation Phenotypes and Clinical Outcomes in Non-Cystic Fibrosis BronchiectasisNon-cystic Fibrosis Bronchiectasis (NCFBE)
NCT06715956Guangzhou Institute of Respiratory Disease400
Completed
Not Applicable
Inflammatory Markers (ICC, MCVL) and Nivolumab Response: Predicting Immunotherapy Success in Metastatic RCCMetastatic Renal Cell Carcinoma
NCT06607809Dr. Lutfi Kirdar Kartal Training and Research Hospital99
Completed
Phase 3
Open Multi-centre Investigation to Evaluate Signs and Symptoms of Local Inflammation/Infection on Chronic Ulcers and Partial Thickness Burns When Using Mepilex Border Ag as an Anti-microbial Wound DressingInflammationBurnsUlcers
NCT01214811Molnlycke Health Care AB27
Unknown
Not Applicable
Assisted or Controlled Ventilation in Ards (Ascovent)ARDSVentilator-Induced Lung InjuryMechanical Ventilation ComplicationInflammatory Response
NCT03245684University of Roma La Sapienza40
Terminated
Phase 2
Predictive Biomarkers of Response to Sunitinib in the Treatment of Poorly-differentiated NEURO-Endocrine TumorsNeuroendocrine TumorsPancreatic NeoplasmsAdvanced DiseaseSunitinib
NCT01215578Assistance Publique - Hôpitaux de Paris33